With a median follow-up of 60 months , the 5-year overall survival ( OS ) rate did not differ significantly between two groups ( 75.5 % vs 79.4 % in CCRT and NACT group respectively , P = 0.47 , HR = 0.84 , 95 % CI 0.53-1 .33 ) .